The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
HPV testing as a screen for cervical cancer
Abstract
Human papillomavirus (HPV) has been identified as a necessary factor in the development of pre-invasive and invasive cancers of the lower genital tract, of which cervical cancer is the most prevalent. A molecular understanding of malignant transformation and epidemiologic information has led to the development of many strategies for detection and early intervention. Newer tests for oncogenic subtypes of HPV have made it possible to predict the risk of future development of cervical cancer. This review summarizes the current understanding of HPV related disease and examines the role of HPV testing as a screening tool for cervical cancer. It summarizes the data from prospective and randomized controlled trials on HPV screening from Europe and North America and includes smaller studies from low and middle income countries where cervical cancer is the most common cancer in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Prevalence of HPV Infection Among Females in the United States
Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E. (2007) · JAMA · doi:10.1001/jama.297.8.813 · Cited by 1,579
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,321
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 936
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W. K., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318287d329 · Cited by 730
Nobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahé, C., & Wright, T. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044278 · Cited by 671
Katki, H. A., Kinney, W. K., Fetterman, B., Lorey, T., Poitras, N. E., Cheung, L., Demuth, F., Schiffman, M., Wacholder, S., & Castle, P. E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70145-0 · Cited by 570
Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
Rodriguez, A. C., Schiffman, M., Herrero, R., Wacholder, S., Hildesheim, A., Castle, P. E., Solomon, D., Burk, R., & On behalf of the Proyecto Epidemiologico Guanacaste Group (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn044 · Cited by 549
Sankaranarayanan, R., Esmy, P. O., Rajkumar, R., Muwonge, R., Swaminathan, R., Shanthakumari, S., Fayette, J.-M., & Cherian, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61195-7 · Cited by 540
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 523
Rijkaart, D. C., Berkhof, J., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W., Heideman, D. A., Kenter, G. G., Cuzick, J., Snijders, P. J., & Meijer, C. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 515
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
Franceschi, S., Herrero, R., Clifford, G. M., Snijders, P. J. F., Arslan, A., Anh, P. T. H., Bosch, F. X., Ferreccio, C., Hieu, N. T., Lazcano‐Ponce, E., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22241 · Cited by 415
Kitchener, H. C., Almonte, M., Thomson, C., Wheeler, P., Sargent, A., Stoykova, B., Gilham, C., Baysson, H., Roberts, C., Dowie, R., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70156-1 · Cited by 388
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Stoler, M. H., Wright, T. C., Sharma, A., Apple, R., Gutekunst, K., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpz5jy6fcvnmot · Cited by 330
Ahdieh, L., Klein, R. S., Burk, R., Cu‐Uvin, S., Schuman, P., Duerr, A., Safaeian, M., Astemborski, J., Daniel, R., & Shah, K. (2001) · The Journal of Infectious Diseases · doi:10.1086/323081 · Cited by 324
Arbyn, M., Sankaranarayanan, R., Muwonge, R., Keita, N., Dolo, A., Mbalawa, C. G., Nouhou, H., Sakande, B., Wesley, R., Somanathan, T., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23489 · Cited by 311
Naucler, P., Ryd, W., Tornberg, S., Strand, A., Wadell, G., Elfgren, K., Radberg, T., Strander, B., Forslund, O., Hansson, B.-G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn444 · Cited by 287
Kinney, W. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00080-5 · Cited by 274
Leinonen, M., Nieminen, P., Kotaniemi-Talonen, L., Malila, N., Tarkkanen, J., Laurila, P., & Anttila, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp367 · Cited by 259
Koliopoulos, G., Arbyn, M., Martin-Hirsch, P., Kyrgiou, M., Prendiville, W., & Paraskevaidis, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.053 · Cited by 254
Wright, T. C., Stoler, M. H., Sharma, A., Zhang, G., Behrens, C., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcptus5exas6dkz · Cited by 226
Cox, J. T., Castle, P. E., Behrens, C. M., Sharma, A., Wright, T. C., & Cuzick, J. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.11.020 · Cited by 210
Screening and cervical cancer cure: population based cohort study
Andrae, B., Andersson, T. M.-L., Lambert, P. C., Kemetli, L., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., Tornberg, S., & Sparen, P. (2012) · BMJ · doi:10.1136/bmj.e900 · Cited by 208
Rositch, A. F., Nowak, R. G., & Gravitt, P. E. (2014) · Cancer · doi:10.1002/cncr.28548 · Cited by 161
Szarewski, A., Mesher, D., Cadman, L., Austin, J., Ashdown-Barr, L., Ho, L., Terry, G., Liddle, S., Young, M., Stoler, M., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00181-12 · Cited by 161
HPV vaccines to prevent cervical cancer and genital warts: an update
Dochez, C., Bogers, J., Verhelst, R., & Rees, H. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.081 · Cited by 152
Datta, S., Koutsky, L. A., Ratelle, S., Unger, E. R., Shlay, J. C., McClain, T., Weaver, B., Kerndt, P. R., Zenilman, J. M., Hagensee, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-7-200804010-00004 · Cited by 146
Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142
The validation of cervical cytology. Sensitivity, specificity and predictive values.
Soost, H.-J., Lange, H. J., Lehmacher, W., & Ruffing-Kullmann, B. (1991) · PubMed · Cited by 127
Castle, P. E., Glass, A. G., Rush, B. B., Scott, D. R., Wentzensen, N., Gage, J. C., Buckland, J., Rydzak, G., Lorincz, A. T., & Wacholder, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8389 · Cited by 113
Coquillard, G., Palao, B., & Patterson, B. K. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.09.013 · Cited by 108
Nanda, K., McCrory, D., Myers, E., Bastian, L., Hasselblad, V., Hickey, J., & Matchar, D. B. (2001) · Journal of Lower Genital Tract Disease · doi:10.1111/j.1526-0976.2001.51012-12.pp.x · Cited by 107
Eklund, C., Forslund, O., Wallin, K., & Dillner, J. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02453-13 · Cited by 91
Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS
Katki, H. A., SCHIFFMAN, M. H., Castle, P. E., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Cheung, L. C., Raine‐Bennett, T. R., Gage, J. C., & Kinney, W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31828543c5 · Cited by 91
Ogilvie, G. S., Krajden, M., van Niekerk, D. J., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Smith, L., Kan, L., Cook, D. A., Peacock, S. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.489 · Cited by 84
Smelov, V., Elfström, K. M., Johansson, A. L. V., Eklund, C., Nauclér, P., Arnheim‐Dahlström, L., & Dillner, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.29085 · Cited by 66
Zorzi, M., Mistro, A. D., Farruggio, A., Bartolomeis, L. D., Frayle, H., Baboçi, L., Bertazzo, A., Cocco, P., Fedato, C., Gennaro, M., et al. (2013) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12272 · Cited by 56
Screening for Cervical Cancer: A Modeling Study for the US Preventive Services Task Force
Kulasingam, S., Havrilesky, L. J., Ghebre, R. G., & Myers, E. R. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3182616241 · Cited by 55
Suba, E. J., Hung, N. C., Duc, N. B., Raab, S. S., & Viet/American Cervical Cancer Prevention Project (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<928::aid-cncr1082>3.0.co;2-s · Cited by 54
Pan, Q., Hu, S., Guo, H., Zhang, W., Zhang, X., Chen, W., Cao, J., Jiang, Y. L., Zhao, F., & Qiao, Y. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.008 · Cited by 50
Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study
Zoodsma, M., Nolte, I. M., Schipper, M., Oosterom, E., van der Steege, G., de Vries, E. G. E., Meerman, T. G., & Zee, V. D. A. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031351 · Cited by 50
Primary human papillomavirus testing in organized cervical screening
Dillner, J. (2013) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32835c5d10 · Cited by 44
Liu, S., Cummings, D. A. T., Zenilman, J. M., Gravitt, P. E., & Brotman, R. M. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0666 · Cited by 44
Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach
Kawana, K. (2012) · The Open Virology Journal · doi:10.2174/1874357901206010264 · Cited by 41
Prevalence and persistence of human papillomavirus in postmenopausal age women
Smith, E., Ritchie, J. M., Levy, B. T., Zhang, W., Wang, D., Haugen, T. H., & Turek, L. P. (2003) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(03)00104-1 · Cited by 40
Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women
Aklimunnessa, K., Mori, M., Khan, M. M. H., Sakauchi, F., Kubo, T., Fujino, Y., Suzuki, S., Tokudome, S., Tamakoshi, A., Motohashi, Y., et al. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl060 · Cited by 39
Thomsen, L. T., Frederiksen, K., Munk, C., Junge, J., Castle, P. E., Iftner, T., & Kjær, S. K. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000056 · Cited by 35
Human Papillomavirus Genotypes and Cervical Cancer in Northeast Thailand
Natphopsuk, S., Settheetham‐Ishida, W., Pientong, C., Sinawat, S., Yuenyao, P., Ishida, T., & Settheetham, D. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6961 · Cited by 34
Sensitivity, specificity, and predictive values
Lheureux, P. E. R. (1998) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(98)90077-8 · Cited by 30
Schmeink, C. E., Massuger, L. F. A. G., Lenselink, C. H., Quint, W. G. V., Melchers, W. J. G., & Bekkers, R. L. M. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e238f0 · Cited by 19
An, H. J., Sung, J. M., Park, A. R., Song, K., Lee, Y. N., Kim, Y. T., Cha, Y. J., Kang, S., & Cho, N. H. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.10.024 · Cited by 7
Cited by
Repurposing Type I-A CRISPR-Cas3 for a robust diagnosis of human papillomavirus (HPV)
Hu, T., Ji, Q., Ke, X., Zhou, H., Zhang, S., Ma, S., Yu, C., Ju, W., Lu, M., Lin, Y., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06537-3 · Cited by 24
Identification of lysine acetylome in cervical cancer by label-free quantitative proteomics
Zhang, L., Wang, W., Zhang, S., Wang, Y., Guo, W., Liu, Y., Wang, Y., & Zhang, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01266-z · Cited by 15
Metadata
- Authors
- Goodman, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2015-06-30
- Volume
- 350
- Issue
- jun30 1
- Pages
- h2372-h2372
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2126649352
- Cited by
- 262
- References
- 62
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.